Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cidara Therapeutics Inc.
DescriptionInitial candidate for Cloudbreak immunotherapy platform
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAspergillus
Indication DetailsTreat invasive aspergillosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today